Shares in ElectroCore, ( $ECOR ) doubled after the U.S. FDA issued an Emergency Use Authorization (EUA) for the use of its gammaCore Sapphire device to treat adult patients with COVID-19.

$LLY $ABT $RGEN $JNJ $SRNE $IBIO $GVAX #nasdaq #stocks https://t.co/qxjwj2YTTE https://t.co/uT62573NCp